Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism
Open Access
Abstract
The isoquinoline alkaloid berberine, derived from Coptidis rhizoma, exhibits antibacterial, hypoglycemic, and anti-inflammatory properties. Canagliflozin is a sodium–glucose cotransporter 2 (SGLT2) inhibitor. We synthesized compounds B9OC and B9OBU by conjugating canagliflozin and n-butane at the C9 position of berberine, aiming to develop antimicrobial agents for combating bacterial infections worldwide. We utilized clinically prevalent pathogenic bacteria, namely Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, to investigate the antibacterial efficacy of B9OC. This was accomplished through the determination of the MIC80 values, analysis of bacterial growth curves, evaluation of biofilm formation using crystal violet staining, assessment of impact on bacterial proteins via SDS-PAGE analysis, and observation of alterations in bacterial morphology utilizing field emission scanning electron microscopy. Meanwhile, the ADMET of compound B9OC was predicted using a computer-aided method. The findings revealed that B9OC exhibited lower minimal inhibitory concentrations against all three bacteria compared to berberine alone or in combination with canagliflozin. The minimal inhibitory concentrations (MICs) of B9OC against the three experimental strains were determined to be 0.035, 0.258, and 0.331 mM. However, B9OBu exhibited a lower level of antimicrobial activity compared to berberine. The compound B9OC exhibits a broad spectrum of antibacterial activity by disrupting the integrity of bacterial cell walls, leading to cellular rupture and the subsequent degradation of intracellular proteins.Keywords
Funding Information
- Hunan natural science foundation Program Project (2023JJ50462, SWGC-02)
- Huaihua University Progra (2023JJ50462, SWGC-02)
This publication has 28 references indexed in Scilit:
- Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetesDiabetes, Obesity and Metabolism, 2019
- Novel berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studiesChinese Journal of Natural Medicines, 2018
- Berberine Derivatives with Different Pharmacological Activities via Structural ModificationsMini-Reviews in Medicinal Chemistry, 2018
- Synthesis and Evolution of Berberine Derivatives as a New Class of Antiviral Agents against Enterovirus 71 through the MEK/ERK Pathway and AutophagyMolecules, 2018
- Synthesis, Characterization, and Biological Evaluations of 1,3,5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium MethylateMolecules, 2017
- The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivativesEuropean Journal of Medicinal Chemistry, 2017
- Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trialsDiabetes, Obesity and Metabolism, 2016
- Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic miceChinese Journal of Natural Medicines, 2016
- Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabeticsBioorganic & Medicinal Chemistry Letters, 2014
- Spacer length and attaching position-dependent binding of synthesized protoberberine dimers to double-stranded DNABioorganic & Medicinal Chemistry, 2006